2024

Petermann-Rocha, F., Zhou, Z. , Mathers, J. C., Celis-Morales, C. , Raubenheimer, D., Sattar, N. , Pell, J. P., Forrest, E. and Ho, F. K. (2024) Diet modifies the association between alcohol consumption and severe alcohol-related liver disease incidence. Nature Communications, 15(1), 6880. (doi: 10.1038/s41467-024-51314-9) (PMID:39128919) (PMCID:PMC11317484)

Petermann-Rocha, F. et al. (2024) Association of five diet scores with severe NAFLD incidence: a prospective study from UK Biobank. Diabetes, Obesity and Metabolism, 26(3), pp. 860-870. (doi: 10.1111/dom.15378) (PMID:37997550) (PMCID:PMC11497349)

2023

Forrest, E. and Bernal, W. (2023) The role of prophylactic antibiotics for patients with severe alcohol-related hepatitis. JAMA: Journal of the American Medical Association, 329(18), pp. 1552-1553. (doi: 10.1001/jama.2023.1729) (PMID:37159045)

Petermann-Rocha, F. et al. (2023) Associations between an inflammatory diet index and severe non-alcoholic fatty liver disease: a prospective study of 171,544 UK Biobank participants. BMC Medicine, 21, 123. (doi: 10.1186/s12916-023-02793-y) (PMID:37013578) (PMCID:PMC10071692)

Curran, C., Priest, M., Datta, S., Forrest, E. H., Stanley, A. J. and Barclay, S. T. (2023) Hepatocellular carcinoma risk scores predict patients under surveillance at low risk of benefit and high risk of harm. Digestive Diseases and Sciences, 68, pp. 770-777. (doi: 10.1007/s10620-022-07731-1) (PMID:36376575)

2022

Crocombe, D. et al. (2022) ASEPTIC: primary antibiotic prophylaxis using co-trimoxazole to prevent SpontanEous bacterial PeritoniTIs in Cirrhosis—study protocol for an interventional randomised controlled trial. Trials, 23, 812. (doi: 10.1186/s13063-022-06727-6) (PMID:36167573) (PMCID:PMC9513307)

Chaudhary, S., MacKey, W., Duncan, K. and Forrest, E. H. (2022) Changes in hospital discharges with alcohol-related liver disease in a gastroenterology and general medical unit following the introduction of minimum unit pricing of alcohol: the GRI Q4 study. Alcohol and Alcoholism, 57(4), pp. 477-482. (doi: 10.1093/alcalc/agab051) (PMID:34343256)

Seth, S. , Forrest, E. H., Morris, J. M., Heydtmann, M., Konanahalli, P., Kohnen, G. and Oien, K. A. (2022) Audit of medical (non-targeted) liver biopsy specimen quality, pathology reporting and effect on patient management. Journal of Clinical Pathology, 75(7), pp. 498-502. (doi: 10.1136/jclinpath-2020-207366) (PMID:34039666)

Ho, F. K. et al. (2022) Association of gamma-glutamyltransferase levels with total mortality, liver-related, and cardiovascular outcomes: a prospective cohort study in the UK Biobank. EClinicalMedicine, 48, 101435. (doi: 10.1016/j.eclinm.2022.101435) (PMID:35706481) (PMCID:PMC9112033)

Nicoll, R., Gerasimidis, K. and Forrest, E. (2022) The role of micronutrients in the pathogenesis of alcohol-related liver disease. Alcohol and Alcoholism, 57(3), pp. 275-282. (doi: 10.1093/alcalc/agab060) (PMID:34491307)

Petermann-Rocha, F., Gray, S. R. , Forrest, E., Welsh, P. , Sattar, N. , Celis-Morales, C. , Ho, F. K. and Pell, J. P. (2022) Associations of muscle mass and grip strength with severe NAFLD: a prospective study of 333,295 UK Biobank participants. Journal of Hepatology, 76(5), pp. 1021-1029. (doi: 10.1016/j.jhep.2022.01.010) (PMID:35085594)

Maguire, D. et al. (2022) Randomised trial of intravenous thiamine and/or magnesium sulphate administration on erythrocyte transketolase activity, lactate concentrations and alcohol withdrawal scores. Scientific Reports, 12, 6941. (doi: 10.1038/s41598-022-10970-x) (PMID:35484175) (PMCID:PMC9051209)

Forrest, E. and Goldin, R. (2022) Letter: the value of quality liver biopsy before initiation of corticosteroids for severe alcoholic hepatitis‐authors' reply. Alimentary Pharmacology and Therapeutics, 55(8), p. 1072. (doi: 10.1111/apt.16890) (PMID:35362124)

2021

Vergis, N. et al. (2021) IL-1 Signal Inhibition In Alcoholic Hepatitis (ISAIAH): a study protocol for a multicentre, randomised, placebo-controlled trial to explore the potential benefits of canakinumab in the treatment of alcoholic hepatitis. Trials, 22, 792. (doi: 10.1186/s13063-021-05719-2) (PMID:34763711) (PMCID:PMC8581959)

Forrest, E. and Goldin, R. (2021) Letter: the diagnostic and prognostic significance of liver histology in alcoholic hepatitis—authors' reply. Alimentary Pharmacology and Therapeutics, 54(6), p. 864. (doi: 10.1111/apt.16559) (PMID:34425009)

Haq, M. I. et al. (2021) Effect of hepatocellular carcinoma surveillance programmes on overall survival in a mixed cirrhotic UK population: a prospective, longitudinal cohort study. Journal of Clinical Medicine, 10(13), 2770. (doi: 10.3390/jcm10132770) (PMID:34202593) (PMCID:PMC8269358)

Forrest, E. et al. (2021) The diagnostic and prognostic significance of liver histology in alcoholic hepatitis. Alimentary Pharmacology and Therapeutics, 53(3), pp. 426-431. (doi: 10.1111/apt.16157) (PMID:33326633)

2019

Maguire, D. et al. (2019) A prospective evaluation of thiamine and magnesium status in relation to clinicopathological characteristics and 1-year mortality in patients with Alcohol Withdrawal Syndrome. Journal of Translational Medicine, 17, 384. (doi: 10.1186/s12967-019-02141-w) (PMID:31752901) (PMCID:PMC6873772)

Maguire, D. et al. (2019) Low serum magnesium and 1-year mortality in alcohol withdrawal syndrome. European Journal of Clinical Investigation, 49(9), e13152. (doi: 10.1111/eci.13152) (PMID:31216056)

2016

Bulteel, N. et al. (2016) Factors associated with spontaneous clearance of chronic hepatitis C virus infection. Journal of Hepatology, 65(2), pp. 266-272. (doi: 10.1016/j.jhep.2016.04.030) (PMID:27155531)

McPeake, J. , Forrest, E., Quasim, T. , Kinsella, J. and O'Neill, A. (2016) The health and social consequences of an alcohol related admission to critical care: a qualitative study. BMJ Open, 6(4), e009944. (doi: 10.1136/bmjopen-2015-009944) (PMID:27048633) (PMCID:PMC4823434)

2015

Campbell, J. et al. (2015) Validation of a prognostic scoring system for critically ill patients with cirrhosis admitted to ICU. Critical Care, 19, 364. (doi: 10.1186/s13054-015-1070-y)

Blasco-Perrin, H. et al. (2015) Hepatitis e virus in patients with decompensated chronic liver disease: a prospective UK/French study. Alimentary Pharmacology and Therapeutics, 42(5), pp. 574-581. (doi: 10.1111/apt.13309) (PMID:26174470)

Campbell, J. et al. (2015) Validation and analysis of prognostic scoring systems for critically ill patients with cirrhosis admitted to ICU. Journal of the Intensive Care Society, 16(3), p. 240. (doi: 10.1177/1751143715584779)

McPeake, J. M. , Shaw, M., O’Neill, A., Forrest, E., Puxty, A., Quasim, T. and Kinsella, J. (2015) Do alcohol use disorders impact on long term outcomes from intensive care? Critical Care, 19, 185. (doi: 10.1186/s13054-015-0909-6) (PMID:25899245) (PMCID:PMC4440292)

2014

Emerson, P., McPeake, J. , O'Neill, A., Gilmour, H., Forrest, E., Puxty, A., Kinsella, J. and Shaw, M. (2014) The utility of scoring systems in critically ill cirrhotic patients admitted to a general intensive care unit. Journal of Critical Care, 29(6), 1131.e1-1131.e6. (doi: 10.1016/j.jcrc.2014.06.027)

McPeake, J. , O'Neill, A., Forrest, E., Quasim, T. and Kinsella, J. (2014) A qualitative study exploring the impact of alcohol use disorders on recovery from ICU. Critical Care Medicine, 42(12), A1508. (doi: 10.1097/01.ccm.0000458113.68944.0a)

McPeake, J. , Shaw, M., O'Neill, A., Puxty, A., Forrest, E., Quasim, T. and Kinsella, J. (2014) Alcohol related admissions to ICU: an 18 month prospective cohort study. Critical Care Medicine, 42(12), A1459. (doi: 10.1097/01.ccm.0000457908.64853.59)

Stanley, A. J. et al. (2014) Multicentre randomised controlled study comparing carvedilol with variceal band ligation in the prevention of variceal rebleeding. Journal of Hepatology, 61(5), pp. 1014-1019. (doi: 10.1016/j.jhep.2014.06.015) (PMID:24953021)

Mustafa, M. Z. et al. (2014) The efficacy and safety of treating hepatitis C in patients with a diagnosis of schizophrenia. Journal of Viral Hepatitis, 21(7), e48-e51. (doi: 10.1111/jvh.12234) (PMID:24533990)

Emerson, P., McPeake, J. , O'Neill, A., Gilmour, H., Puxty, A., Forrest, E. and Kinsella, J. (2014) Organ failure, outcomes and deprivation status among critically ill cirrhosis patients — a one-year cohort study. Journal of the Intensive Care Society, 15(2), pp. 178-179.

Reed, E. A. et al. (2014) Is the Glasgow Blatchford score useful in the risk assessment of patients presenting with variceal haemorrhage? European Journal of Gastroenterology and Hepatology, 26(4), pp. 432-437. (doi: 10.1097/MEG.0000000000000051) (PMID:24535596)

Sattar, N. , Forrest, E. and Preiss, D. (2014) Non-alcoholic fatty liver disease. British Medical Journal, 2014(349), g4596. (doi: 10.1136/bmj.g4596) (PMID:25239614) (PMCID:PMC4168663)

2013

Emerson, P., McPeake, J. , O'Neill, A., Gilmour, H., Forrest, E. and Kinsella, J. (2013) The utility of scoring systems in critically ill patients with cirrhosis admitted to a general ICU. Critical Care Medicine, 41(12), A184-A185. (doi: 10.1097/01.ccm.0000439983.09121.d6)

Lafferty, H., Stanley, A.J. and Forrest, E.H. (2013) The management of alcoholic hepatitis: a prospective comparison of scoring systems. Alimentary Pharmacology and Therapeutics, 38(6), pp. 603-610. (doi: 10.1111/apt.12414) (PMID:23879668)

2012

Moyes, L.H., Hamid, R., Clutton, J., Oien, K.A. , McKee, R.F. and Forrest, E.H. (2012) Improvement of parenteral nutrition-associated cholestasis in an adult using fish oil-based parenteral nutrition. Frontline Gastroenterology, 3(2), pp. 94-97. (doi: 10.1136/flgastro-2011-100056) (PMID:28839644) (PMCID:PMC5517263)

Anderson, B.H. et al. (2012) Mutations in CTC1, encoding conserved telomere maintenance component 1, cause Coats plus. Nature Genetics, 44(3), pp. 338-342. (doi: 10.1038/ng.1084) (PMID:22267198)

2011

Rajoriya, N., Forrest, E.H., Gray, J., Stuart, R.C., Carter, R.C., Mackay, C.J., Gaya, D.R., Morris, A.J. and Stanley, A.J. (2011) Long-term follow-up of endoscopic histoacryl glue injection for the management of gastric variceal bleeding. QJM: An International Journal of Medicine, 104(1), pp. 41-47. (doi: 10.1093/qjmed/hcq161) (PMID:20871126)

2010

Barclay, S.T. et al. (2010) The changing face of hepatitis B in greater Glasgow: epidemiological trends 1993-2007. Scottish Medical Journal, 55(3), pp. 4-7. (doi: 10.1258/rsmsmj.55.3.4) (PMID:20795508)

Morris, J.M., Oien, K.A. , McMahon, M., Forrest, E.H., Morris, J.M., Stanley, A.J. and Campbell, S. (2010) Nodular regenerative hyperplasia of the liver: survival and associated features in a UK case series. European Journal of Gastroenterology and Hepatology, 22(8), pp. 1001-1005. (doi: 10.1097/MEG.0b013e3283360021)

2009

Tripathi, D. et al. (2009) Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed. Hepatology, 50(3), pp. 825-833. (doi: 10.1002/hep.23045) (PMID:19610055)

2007

Gaya, D. R., Lyon, T. D. B., Clarke, J., Jamdar, S., Inverarity, D., Forrest, E. H., Morris, A. J. and Stanley, A. J. (2007) Bedside leucocyte esterase reagent strips with spectrophotometric analysis to rapidly exclude spontaneous bacterial peritonitis: a pilot study. European Journal of Gastroenterology and Hepatology, 19(4), pp. 289-295. (doi: 10.1097/MEG.0b013e328013e991) (PMID:17353692) (PMCID:17353692)

2004

Tripathi, D., Lui, H.F., Helmy, A., Dabos, K., Forrest, E., Stanley, A.J. , Jalan, R., Redhead, D.N. and Hayes, P.C. (2004) Randomised controlled trial of long term portographic follow up versus variceal band ligation following transjugular intrahepatic portosystemic stent shunt for preventing oesophageal variceal rebleeding. Gut, 53(3), pp. 431-437. (doi: 10.1136/gut.2003.013532) (PMID:14960530) (PMCID:PMC1773959)

2002

Lui, H. F., Stanley, A. J. , Forrest, E. H., Rajiv, J., Hislop, W. S., Mills, P. R., Finlayson, N. D.C., MacGilchrist, A. and Hayes, P. C. (2002) Primary prophylaxis of variceal hemorrhage: a randomized controlled trial comparing band ligation, propranolol, and isosorbide mononitrate. Gastroenterology, 123(3), pp. 735-744. (doi: 10.1053/gast.2002.35385) (PMID:12198700)

2000

Fleet, M., Stanley, A.J. , Forrest, E.H., Hayes, P.C. and Redhead, D.N. (2000) Transjugular intrahepatic portosystemic stent shunt placement in a patient with cystic fibrosis complicated by portal hypertension. Clinical Radiology, 55(3), pp. 236-237. (doi: 10.1053/crad.1999.0077) (PMID:10708619)

Forrest, E., Stanley, A. and Hayes, P. (2000) Carvedilol - A new nonselective beta blocker. Hepatology, 31(3), pp. 809-811. (doi: 10.1002/hep.510310341)

1998

Stanley, A. J. , Forrest, E. H., Dabos, K., Bouchier, I. A.D. and Hayes, P. C. (1998) Natriuretic effect of an adenosine-1 receptor antagonist in cirrhotic patients with ascites. Gastroenterology, 115(2), pp. 406-411. (doi: 10.1016/S0016-5085(98)70207-0) (PMID:9679046)

Stanley, A. J. , Forrest, E. H., Redhead, D. N., Bouchier, I. A.D. and Hayes, P. C. (1998) Direct measurement of post-prandial portal haemodynamics in cirrhotic patients with a transjugular intrahepatic portosystemic stent-shunt. European Journal of Gastroenterology and Hepatology, 10(5), pp. 393-397. (PMID:9619385)

Stanley, A.J. , Forrest, E.H., Dabos, K.J., MacGilchrist, A.J. and Hayes, P.C. (1998) Comparison between theophylline and spironolactone in the management of cirrhotic ascites: a randomized controlled study. Alimentary Pharmacology and Therapeutics, 12(4), pp. 389-393. (doi: 10.1046/j.1365-2036.1998.00318.x) (PMID:9690731)

Stanley, A.J. , Robinson, I., Forrest, E. H., Jones, A.L. and Hayes, P.C. (1998) Haemodynamic parameters predicting variceal haemorrhage and survival in alcoholic cirrhosis. QJM: An International Journal of Medicine, 91(1), pp. 19-25. (doi: 10.1093/qjmed/91.1.19) (PMID:9519209)

1997

Jalan, R., Forrest, E. H., Stanley, A. J. , Redhead, D. N., Forbes, J., Dillon, J. F., MacGilchrist, A. J., Finlayson, N. D.C. and Hayes, P. C. (1997) A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices. Hepatology, 26(5), pp. 1115-1122. (doi: 10.1053/jhep.1997.v26.pm0009362350) (PMID:9362350)

1996

Forrest, E.H., Stanley, A.J. , Redhead, D.N., McGilchrist, A.J. and Hayes, P.C. (1996) Clinical response after transjugular intrahepatic portosystemic stent shunt insertion for refractory ascites in cirrhosis. Alimentary Pharmacology and Therapeutics, 10(5), pp. 801-806. (doi: 10.1046/j.1365-2036.1996.60202000.x) (PMID:8899090)

Stanley, A.J. , Jalan, R., Forrest, E.H., Redhead, D.N. and Hayes, P.C. (1996) Longterm follow up of transjugular intrahepatic portosystemic stent shunt (TIPSS) for the treatment of portal hypertension: results in 130 patients. Gut, 39(3), pp. 479-485. (doi: 10.1136/gut.39.3.479) (PMID:8949658) (PMCID:PMC1383360)

Articles

Petermann-Rocha, F., Zhou, Z. , Mathers, J. C., Celis-Morales, C. , Raubenheimer, D., Sattar, N. , Pell, J. P., Forrest, E. and Ho, F. K. (2024) Diet modifies the association between alcohol consumption and severe alcohol-related liver disease incidence. Nature Communications, 15(1), 6880. (doi: 10.1038/s41467-024-51314-9) (PMID:39128919) (PMCID:PMC11317484)

Petermann-Rocha, F. et al. (2024) Association of five diet scores with severe NAFLD incidence: a prospective study from UK Biobank. Diabetes, Obesity and Metabolism, 26(3), pp. 860-870. (doi: 10.1111/dom.15378) (PMID:37997550) (PMCID:PMC11497349)

Forrest, E. and Bernal, W. (2023) The role of prophylactic antibiotics for patients with severe alcohol-related hepatitis. JAMA: Journal of the American Medical Association, 329(18), pp. 1552-1553. (doi: 10.1001/jama.2023.1729) (PMID:37159045)

Petermann-Rocha, F. et al. (2023) Associations between an inflammatory diet index and severe non-alcoholic fatty liver disease: a prospective study of 171,544 UK Biobank participants. BMC Medicine, 21, 123. (doi: 10.1186/s12916-023-02793-y) (PMID:37013578) (PMCID:PMC10071692)

Curran, C., Priest, M., Datta, S., Forrest, E. H., Stanley, A. J. and Barclay, S. T. (2023) Hepatocellular carcinoma risk scores predict patients under surveillance at low risk of benefit and high risk of harm. Digestive Diseases and Sciences, 68, pp. 770-777. (doi: 10.1007/s10620-022-07731-1) (PMID:36376575)

Crocombe, D. et al. (2022) ASEPTIC: primary antibiotic prophylaxis using co-trimoxazole to prevent SpontanEous bacterial PeritoniTIs in Cirrhosis—study protocol for an interventional randomised controlled trial. Trials, 23, 812. (doi: 10.1186/s13063-022-06727-6) (PMID:36167573) (PMCID:PMC9513307)

Chaudhary, S., MacKey, W., Duncan, K. and Forrest, E. H. (2022) Changes in hospital discharges with alcohol-related liver disease in a gastroenterology and general medical unit following the introduction of minimum unit pricing of alcohol: the GRI Q4 study. Alcohol and Alcoholism, 57(4), pp. 477-482. (doi: 10.1093/alcalc/agab051) (PMID:34343256)

Seth, S. , Forrest, E. H., Morris, J. M., Heydtmann, M., Konanahalli, P., Kohnen, G. and Oien, K. A. (2022) Audit of medical (non-targeted) liver biopsy specimen quality, pathology reporting and effect on patient management. Journal of Clinical Pathology, 75(7), pp. 498-502. (doi: 10.1136/jclinpath-2020-207366) (PMID:34039666)

Ho, F. K. et al. (2022) Association of gamma-glutamyltransferase levels with total mortality, liver-related, and cardiovascular outcomes: a prospective cohort study in the UK Biobank. EClinicalMedicine, 48, 101435. (doi: 10.1016/j.eclinm.2022.101435) (PMID:35706481) (PMCID:PMC9112033)

Nicoll, R., Gerasimidis, K. and Forrest, E. (2022) The role of micronutrients in the pathogenesis of alcohol-related liver disease. Alcohol and Alcoholism, 57(3), pp. 275-282. (doi: 10.1093/alcalc/agab060) (PMID:34491307)

Petermann-Rocha, F., Gray, S. R. , Forrest, E., Welsh, P. , Sattar, N. , Celis-Morales, C. , Ho, F. K. and Pell, J. P. (2022) Associations of muscle mass and grip strength with severe NAFLD: a prospective study of 333,295 UK Biobank participants. Journal of Hepatology, 76(5), pp. 1021-1029. (doi: 10.1016/j.jhep.2022.01.010) (PMID:35085594)

Maguire, D. et al. (2022) Randomised trial of intravenous thiamine and/or magnesium sulphate administration on erythrocyte transketolase activity, lactate concentrations and alcohol withdrawal scores. Scientific Reports, 12, 6941. (doi: 10.1038/s41598-022-10970-x) (PMID:35484175) (PMCID:PMC9051209)

Forrest, E. and Goldin, R. (2022) Letter: the value of quality liver biopsy before initiation of corticosteroids for severe alcoholic hepatitis‐authors' reply. Alimentary Pharmacology and Therapeutics, 55(8), p. 1072. (doi: 10.1111/apt.16890) (PMID:35362124)

Vergis, N. et al. (2021) IL-1 Signal Inhibition In Alcoholic Hepatitis (ISAIAH): a study protocol for a multicentre, randomised, placebo-controlled trial to explore the potential benefits of canakinumab in the treatment of alcoholic hepatitis. Trials, 22, 792. (doi: 10.1186/s13063-021-05719-2) (PMID:34763711) (PMCID:PMC8581959)

Forrest, E. and Goldin, R. (2021) Letter: the diagnostic and prognostic significance of liver histology in alcoholic hepatitis—authors' reply. Alimentary Pharmacology and Therapeutics, 54(6), p. 864. (doi: 10.1111/apt.16559) (PMID:34425009)

Haq, M. I. et al. (2021) Effect of hepatocellular carcinoma surveillance programmes on overall survival in a mixed cirrhotic UK population: a prospective, longitudinal cohort study. Journal of Clinical Medicine, 10(13), 2770. (doi: 10.3390/jcm10132770) (PMID:34202593) (PMCID:PMC8269358)

Forrest, E. et al. (2021) The diagnostic and prognostic significance of liver histology in alcoholic hepatitis. Alimentary Pharmacology and Therapeutics, 53(3), pp. 426-431. (doi: 10.1111/apt.16157) (PMID:33326633)

Maguire, D. et al. (2019) A prospective evaluation of thiamine and magnesium status in relation to clinicopathological characteristics and 1-year mortality in patients with Alcohol Withdrawal Syndrome. Journal of Translational Medicine, 17, 384. (doi: 10.1186/s12967-019-02141-w) (PMID:31752901) (PMCID:PMC6873772)

Maguire, D. et al. (2019) Low serum magnesium and 1-year mortality in alcohol withdrawal syndrome. European Journal of Clinical Investigation, 49(9), e13152. (doi: 10.1111/eci.13152) (PMID:31216056)

Bulteel, N. et al. (2016) Factors associated with spontaneous clearance of chronic hepatitis C virus infection. Journal of Hepatology, 65(2), pp. 266-272. (doi: 10.1016/j.jhep.2016.04.030) (PMID:27155531)

McPeake, J. , Forrest, E., Quasim, T. , Kinsella, J. and O'Neill, A. (2016) The health and social consequences of an alcohol related admission to critical care: a qualitative study. BMJ Open, 6(4), e009944. (doi: 10.1136/bmjopen-2015-009944) (PMID:27048633) (PMCID:PMC4823434)

Campbell, J. et al. (2015) Validation of a prognostic scoring system for critically ill patients with cirrhosis admitted to ICU. Critical Care, 19, 364. (doi: 10.1186/s13054-015-1070-y)

Blasco-Perrin, H. et al. (2015) Hepatitis e virus in patients with decompensated chronic liver disease: a prospective UK/French study. Alimentary Pharmacology and Therapeutics, 42(5), pp. 574-581. (doi: 10.1111/apt.13309) (PMID:26174470)

Campbell, J. et al. (2015) Validation and analysis of prognostic scoring systems for critically ill patients with cirrhosis admitted to ICU. Journal of the Intensive Care Society, 16(3), p. 240. (doi: 10.1177/1751143715584779)

McPeake, J. M. , Shaw, M., O’Neill, A., Forrest, E., Puxty, A., Quasim, T. and Kinsella, J. (2015) Do alcohol use disorders impact on long term outcomes from intensive care? Critical Care, 19, 185. (doi: 10.1186/s13054-015-0909-6) (PMID:25899245) (PMCID:PMC4440292)

Emerson, P., McPeake, J. , O'Neill, A., Gilmour, H., Forrest, E., Puxty, A., Kinsella, J. and Shaw, M. (2014) The utility of scoring systems in critically ill cirrhotic patients admitted to a general intensive care unit. Journal of Critical Care, 29(6), 1131.e1-1131.e6. (doi: 10.1016/j.jcrc.2014.06.027)

McPeake, J. , O'Neill, A., Forrest, E., Quasim, T. and Kinsella, J. (2014) A qualitative study exploring the impact of alcohol use disorders on recovery from ICU. Critical Care Medicine, 42(12), A1508. (doi: 10.1097/01.ccm.0000458113.68944.0a)

McPeake, J. , Shaw, M., O'Neill, A., Puxty, A., Forrest, E., Quasim, T. and Kinsella, J. (2014) Alcohol related admissions to ICU: an 18 month prospective cohort study. Critical Care Medicine, 42(12), A1459. (doi: 10.1097/01.ccm.0000457908.64853.59)

Stanley, A. J. et al. (2014) Multicentre randomised controlled study comparing carvedilol with variceal band ligation in the prevention of variceal rebleeding. Journal of Hepatology, 61(5), pp. 1014-1019. (doi: 10.1016/j.jhep.2014.06.015) (PMID:24953021)

Mustafa, M. Z. et al. (2014) The efficacy and safety of treating hepatitis C in patients with a diagnosis of schizophrenia. Journal of Viral Hepatitis, 21(7), e48-e51. (doi: 10.1111/jvh.12234) (PMID:24533990)

Emerson, P., McPeake, J. , O'Neill, A., Gilmour, H., Puxty, A., Forrest, E. and Kinsella, J. (2014) Organ failure, outcomes and deprivation status among critically ill cirrhosis patients — a one-year cohort study. Journal of the Intensive Care Society, 15(2), pp. 178-179.

Reed, E. A. et al. (2014) Is the Glasgow Blatchford score useful in the risk assessment of patients presenting with variceal haemorrhage? European Journal of Gastroenterology and Hepatology, 26(4), pp. 432-437. (doi: 10.1097/MEG.0000000000000051) (PMID:24535596)

Sattar, N. , Forrest, E. and Preiss, D. (2014) Non-alcoholic fatty liver disease. British Medical Journal, 2014(349), g4596. (doi: 10.1136/bmj.g4596) (PMID:25239614) (PMCID:PMC4168663)

Emerson, P., McPeake, J. , O'Neill, A., Gilmour, H., Forrest, E. and Kinsella, J. (2013) The utility of scoring systems in critically ill patients with cirrhosis admitted to a general ICU. Critical Care Medicine, 41(12), A184-A185. (doi: 10.1097/01.ccm.0000439983.09121.d6)

Lafferty, H., Stanley, A.J. and Forrest, E.H. (2013) The management of alcoholic hepatitis: a prospective comparison of scoring systems. Alimentary Pharmacology and Therapeutics, 38(6), pp. 603-610. (doi: 10.1111/apt.12414) (PMID:23879668)

Moyes, L.H., Hamid, R., Clutton, J., Oien, K.A. , McKee, R.F. and Forrest, E.H. (2012) Improvement of parenteral nutrition-associated cholestasis in an adult using fish oil-based parenteral nutrition. Frontline Gastroenterology, 3(2), pp. 94-97. (doi: 10.1136/flgastro-2011-100056) (PMID:28839644) (PMCID:PMC5517263)

Anderson, B.H. et al. (2012) Mutations in CTC1, encoding conserved telomere maintenance component 1, cause Coats plus. Nature Genetics, 44(3), pp. 338-342. (doi: 10.1038/ng.1084) (PMID:22267198)

Rajoriya, N., Forrest, E.H., Gray, J., Stuart, R.C., Carter, R.C., Mackay, C.J., Gaya, D.R., Morris, A.J. and Stanley, A.J. (2011) Long-term follow-up of endoscopic histoacryl glue injection for the management of gastric variceal bleeding. QJM: An International Journal of Medicine, 104(1), pp. 41-47. (doi: 10.1093/qjmed/hcq161) (PMID:20871126)

Barclay, S.T. et al. (2010) The changing face of hepatitis B in greater Glasgow: epidemiological trends 1993-2007. Scottish Medical Journal, 55(3), pp. 4-7. (doi: 10.1258/rsmsmj.55.3.4) (PMID:20795508)

Morris, J.M., Oien, K.A. , McMahon, M., Forrest, E.H., Morris, J.M., Stanley, A.J. and Campbell, S. (2010) Nodular regenerative hyperplasia of the liver: survival and associated features in a UK case series. European Journal of Gastroenterology and Hepatology, 22(8), pp. 1001-1005. (doi: 10.1097/MEG.0b013e3283360021)

Tripathi, D. et al. (2009) Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed. Hepatology, 50(3), pp. 825-833. (doi: 10.1002/hep.23045) (PMID:19610055)

Gaya, D. R., Lyon, T. D. B., Clarke, J., Jamdar, S., Inverarity, D., Forrest, E. H., Morris, A. J. and Stanley, A. J. (2007) Bedside leucocyte esterase reagent strips with spectrophotometric analysis to rapidly exclude spontaneous bacterial peritonitis: a pilot study. European Journal of Gastroenterology and Hepatology, 19(4), pp. 289-295. (doi: 10.1097/MEG.0b013e328013e991) (PMID:17353692) (PMCID:17353692)

Tripathi, D., Lui, H.F., Helmy, A., Dabos, K., Forrest, E., Stanley, A.J. , Jalan, R., Redhead, D.N. and Hayes, P.C. (2004) Randomised controlled trial of long term portographic follow up versus variceal band ligation following transjugular intrahepatic portosystemic stent shunt for preventing oesophageal variceal rebleeding. Gut, 53(3), pp. 431-437. (doi: 10.1136/gut.2003.013532) (PMID:14960530) (PMCID:PMC1773959)

Lui, H. F., Stanley, A. J. , Forrest, E. H., Rajiv, J., Hislop, W. S., Mills, P. R., Finlayson, N. D.C., MacGilchrist, A. and Hayes, P. C. (2002) Primary prophylaxis of variceal hemorrhage: a randomized controlled trial comparing band ligation, propranolol, and isosorbide mononitrate. Gastroenterology, 123(3), pp. 735-744. (doi: 10.1053/gast.2002.35385) (PMID:12198700)

Fleet, M., Stanley, A.J. , Forrest, E.H., Hayes, P.C. and Redhead, D.N. (2000) Transjugular intrahepatic portosystemic stent shunt placement in a patient with cystic fibrosis complicated by portal hypertension. Clinical Radiology, 55(3), pp. 236-237. (doi: 10.1053/crad.1999.0077) (PMID:10708619)

Forrest, E., Stanley, A. and Hayes, P. (2000) Carvedilol - A new nonselective beta blocker. Hepatology, 31(3), pp. 809-811. (doi: 10.1002/hep.510310341)

Stanley, A. J. , Forrest, E. H., Dabos, K., Bouchier, I. A.D. and Hayes, P. C. (1998) Natriuretic effect of an adenosine-1 receptor antagonist in cirrhotic patients with ascites. Gastroenterology, 115(2), pp. 406-411. (doi: 10.1016/S0016-5085(98)70207-0) (PMID:9679046)

Stanley, A. J. , Forrest, E. H., Redhead, D. N., Bouchier, I. A.D. and Hayes, P. C. (1998) Direct measurement of post-prandial portal haemodynamics in cirrhotic patients with a transjugular intrahepatic portosystemic stent-shunt. European Journal of Gastroenterology and Hepatology, 10(5), pp. 393-397. (PMID:9619385)

Stanley, A.J. , Forrest, E.H., Dabos, K.J., MacGilchrist, A.J. and Hayes, P.C. (1998) Comparison between theophylline and spironolactone in the management of cirrhotic ascites: a randomized controlled study. Alimentary Pharmacology and Therapeutics, 12(4), pp. 389-393. (doi: 10.1046/j.1365-2036.1998.00318.x) (PMID:9690731)

Stanley, A.J. , Robinson, I., Forrest, E. H., Jones, A.L. and Hayes, P.C. (1998) Haemodynamic parameters predicting variceal haemorrhage and survival in alcoholic cirrhosis. QJM: An International Journal of Medicine, 91(1), pp. 19-25. (doi: 10.1093/qjmed/91.1.19) (PMID:9519209)

Jalan, R., Forrest, E. H., Stanley, A. J. , Redhead, D. N., Forbes, J., Dillon, J. F., MacGilchrist, A. J., Finlayson, N. D.C. and Hayes, P. C. (1997) A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices. Hepatology, 26(5), pp. 1115-1122. (doi: 10.1053/jhep.1997.v26.pm0009362350) (PMID:9362350)

Forrest, E.H., Stanley, A.J. , Redhead, D.N., McGilchrist, A.J. and Hayes, P.C. (1996) Clinical response after transjugular intrahepatic portosystemic stent shunt insertion for refractory ascites in cirrhosis. Alimentary Pharmacology and Therapeutics, 10(5), pp. 801-806. (doi: 10.1046/j.1365-2036.1996.60202000.x) (PMID:8899090)

Stanley, A.J. , Jalan, R., Forrest, E.H., Redhead, D.N. and Hayes, P.C. (1996) Longterm follow up of transjugular intrahepatic portosystemic stent shunt (TIPSS) for the treatment of portal hypertension: results in 130 patients. Gut, 39(3), pp. 479-485. (doi: 10.1136/gut.39.3.479) (PMID:8949658) (PMCID:PMC1383360)